Granite FO’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Granite FO's REGN Position: Q3 2026 in Review
Granite FO held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 3 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #139.
Granite FO first reported a position in REGN in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.08M in Q4 2022. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Granite FO held 3 shares of Regeneron Pharmaceuticals worth $2.28K as of Q3 2026.
- Granite FO left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Granite FO's portfolio in Q3 2026, its #139 holding.
- Granite FO first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
- Granite FO's Regeneron Pharmaceuticals position peaked at $1.08M in Q4 2022.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Granite FO's 13F filing for Q3 2026, filed 14 Oct 2026.